Suppr超能文献

神经科医生对深部脑刺激的使用及时机的态度

Neurologists' Attitudes Toward Use and Timing of Deep Brain Stimulation.

作者信息

Cabrera Laura Yenisa, Young Han Catherine, Ostendorf Tasha, Jimenez-Shahed Joohi, Sarva Harini

机构信息

Center for Ethics and Humanities in the Life Sciences (LYC), Department of Translational Neuroscience, Michigan State University, East Lansing, current affiliation: Center for Neural Engineering, Department of Engineering Science and Mechanics, Rock Ethics Institutes, Pennsylvania State University; Weill Cornell Medicine (CYH), New York; American Academy of Neurology (TO), Minneapolis, MN; Bonnie and Tom Strauss Movement Disorders Center (JJ-S), Icahn School of Medicine at Mount Sinai, New York; and Parkinson's Disease and Movement Disorders Institute (HS), Department of Neurology, Weill Cornell Medicine, New York.

出版信息

Neurol Clin Pract. 2021 Dec;11(6):506-516. doi: 10.1212/CPJ.0000000000001098.

Abstract

OBJECTIVE

We sought to explore current perspectives and attitudes of general neurologists and movement disorder specialists toward deep brain stimulation (DBS) for Parkinson disease (PD), focusing on perspectives on its earlier use in the clinical course of the disease.

METHODS

We designed a 30-question online survey comprised of Likert-type, multiple choice, and rank-order questions, which was distributed to 932 neurologist members of the American Academy of Neurology. We analyzed clinicians' sociodemographic information, treatment patterns used for patients with PD, reasons for and against patient referral for DBS, and general attitudes toward DBS. Data were analyzed using descriptive and inferential statistics.

RESULTS

We received 164/930 completed surveys (completion rate of 18%). Overall, most respondents agreed that DBS was more useful after the appearance of motor complications and that DBS utilization offered better management of PD than medication alone. However, respondents were divided on issues like minimum duration of disease needed to consider DBS as a treatment option and timing of DBS referral relative to disease progression. Specifically, differences between movement disorder specialists and general neurologists were seen in medication management of symptoms and dyskinesia.

CONCLUSIONS

There remains a lack of consensus on several aspects of DBS, including medical management before offering DBS and the appropriate timing of its consideration for patients. Given the effect of such lack of consensus on patients' outcomes and recent evidence on positive DBS results, it is essential to update DBS professional guidelines with a focus on medical management and the timely use of DBS.

摘要

目的

我们试图探究普通神经科医生和运动障碍专家对帕金森病(PD)深部脑刺激(DBS)的当前观点和态度,重点关注其在疾病临床过程中更早使用的观点。

方法

我们设计了一项包含30个问题的在线调查,包括李克特式、多项选择和排序问题,该调查分发给了美国神经病学学会的932名神经科医生成员。我们分析了临床医生的社会人口统计学信息、用于PD患者的治疗模式、支持和反对将患者转诊接受DBS的原因以及对DBS的总体态度。使用描述性和推断性统计分析数据。

结果

我们收到了164/930份完整的调查问卷(完成率为18%)。总体而言,大多数受访者同意DBS在运动并发症出现后更有用,并且DBS的应用比单独使用药物能更好地管理PD。然而,在将DBS视为一种治疗选择所需的最短病程以及相对于疾病进展的DBS转诊时机等问题上,受访者存在分歧。具体而言,在症状和异动症的药物管理方面,运动障碍专家和普通神经科医生之间存在差异。

结论

在DBS的几个方面仍缺乏共识,包括在提供DBS之前的药物管理以及对患者考虑使用DBS的适当时间。鉴于这种缺乏共识对患者预后的影响以及最近关于DBS积极结果的证据,更新DBS专业指南以关注药物管理和DBS的及时使用至关重要。

相似文献

1
Neurologists' Attitudes Toward Use and Timing of Deep Brain Stimulation.
Neurol Clin Pract. 2021 Dec;11(6):506-516. doi: 10.1212/CPJ.0000000000001098.
2
Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.
World Neurosurg. 2019 Aug;128:e16-e20. doi: 10.1016/j.wneu.2019.03.051. Epub 2019 Mar 14.
3
Attitudes toward use and timing of deep brain stimulation: a patient's with DBS perspective.
Clin Neurol Neurosurg. 2021 Apr;203:106553. doi: 10.1016/j.clineuro.2021.106553. Epub 2021 Feb 10.
4
Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease.
Neuromodulation. 2011 May-Jun;14(3):208-13; discussion 213. doi: 10.1111/j.1525-1403.2011.00350.x. Epub 2011 Apr 1.
5
How Parkinson's patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide survey.
J Clin Neurosci. 2022 Jan;95:20-26. doi: 10.1016/j.jocn.2021.11.017. Epub 2021 Dec 3.
8
Underutilization of deep brain stimulation for Parkinson's disease? A survey on possible clinical reasons.
Acta Neurochir (Wien). 2017 May;159(5):771-778. doi: 10.1007/s00701-017-3122-3. Epub 2017 Mar 3.

引用本文的文献

1
Education Research: Bridging the Undergraduate Neurosciences With Clinical Neurology: Neuroscience Faculty Perspectives.
Neurol Educ. 2022 Oct 7;1(1):e200005. doi: 10.1212/NE9.0000000000200005. eCollection 2022 Sep.
2
The future of Parkinson's care: a need to expand access.
Front Neurol. 2025 Jun 19;16:1622283. doi: 10.3389/fneur.2025.1622283. eCollection 2025.
3
What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.
J Neural Transm (Vienna). 2024 Nov;131(11):1307-1320. doi: 10.1007/s00702-024-02782-2. Epub 2024 May 15.
4
Know DBS: patient perceptions and knowledge of deep brain stimulation in Parkinson's disease.
Ther Adv Neurol Disord. 2024 Mar 6;17:17562864241233038. doi: 10.1177/17562864241233038. eCollection 2024.
5
Patient Referral for Device-Aided Therapies in Parkinson's Disease is Suboptimal; A Dutch Survey.
Mov Disord Clin Pract. 2023 Nov 11;10(12):1821-1823. doi: 10.1002/mdc3.13913. eCollection 2023 Dec.
6
Accessibility of Device-Aided Therapies for Persons With Parkinson's Disease in Poland.
J Mov Disord. 2024 Apr;17(2):208-212. doi: 10.14802/jmd.23172. Epub 2023 Nov 20.
7
Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review.
J Neural Transm (Vienna). 2023 Nov;130(11):1359-1377. doi: 10.1007/s00702-023-02656-z. Epub 2023 Jul 27.
8
Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty.
J Neural Transm (Vienna). 2023 Nov;130(11):1411-1432. doi: 10.1007/s00702-023-02668-9. Epub 2023 Jul 12.

本文引用的文献

3
Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
Brain Stimul. 2020 Nov-Dec;13(6):1697-1705. doi: 10.1016/j.brs.2020.09.019. Epub 2020 Oct 7.
4
Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.
PLoS One. 2020 Aug 21;15(8):e0237498. doi: 10.1371/journal.pone.0237498. eCollection 2020.
5
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes.
Neurology. 2020 Jul 28;95(4):e393-e401. doi: 10.1212/WNL.0000000000009946. Epub 2020 Jun 29.
7
Canadian guideline for Parkinson disease.
CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504.
8
Cost-Effectiveness of Deep Brain Stimulation With Movement Disorders: A Systematic Review.
Mov Disord Clin Pract. 2019 May 17;6(5):348-358. doi: 10.1002/mdc3.12780. eCollection 2019 Jun.
10
Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.
World Neurosurg. 2019 Aug;128:e16-e20. doi: 10.1016/j.wneu.2019.03.051. Epub 2019 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验